Use of hydroxyprogesterone derivatives for enhancing health and physical performance
申请人:Marchewitz Eric D.
公开号:US20120277201A1
公开(公告)日:2012-11-01
A method for the use of derivatives of hydroxyprogesterone (17-alpha-hydroxypregn-4-ene-3,20-dione) to enhance health and physical performance in humans and more particularly to the use of hydroxyprogesterone derivatives for restoring renal hormonal balance, decreasing body weight, reducing adipose tissue, increasing endurance, promoting skeletal muscle growth, boosting androgen levels, inhibiting aromatase, and increasing cognitive function.
Use of Hydroxyprogesterone Derivatives for Enhanced Health and Physical Performance II
申请人:Marchewitz Eric
公开号:US20190038637A1
公开(公告)日:2019-02-07
A method for the use of derivatives of hydroxyprogesterone (17-alpha-hydroxypregn-4-ene-3,20-dione) to enhance health and physical performance in humans and more particularly to the use of hydroxyprogesterone derivatives for restoring renal hormonal balance, decreasing body weight, reducing adipose tissue, increasing endurance, promoting skeletal muscle growth, boosting androgen levels, inhibiting aromatase, and increasing cognitive function.